Victim Impact Modules for Jail Inmates

Substance Abuse Clinical Trial

Official title:

Phase 1-2 Study of Victim Impact Group Modules for Jail Inmates

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT01381146
• Other study ID #: R01DA014694-12
• Secondary ID: R01DA014694
• Status: Withdrawn
• Phase: N/A
• First received: June 17, 2011
• Last updated: April 21, 2017
• Start date: July 15, 2016
• Est. completion date: July 15, 2016

Study information

• Verified date: April 2017
• Source: George Mason University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate feasibility of modularized delivery of the Impact of Crime (IOC) group intervention with jail inmates, and obtain preliminary data on its effectiveness in reducing post-release recidivism, substance abuse, and HIV risk behavior.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: July 15, 2016
• Est. primary completion date: July 15, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Must be 18 years or older

• Must be male

• Must be currently incarcerated jail inmate

• Must be sentenced

• Sentence must be short enough to serve out sentence at ADC

• Release date must follow projected final session of treatment

• Must speak, read, and write in English with sufficient proficiency to use workbook and participate in group sessions

• Must be assigned to the jail's "general population"

Exclusion Criteria:

• Actively psychotic

• Assigned "keep separate" from other group members

Related Conditions & MeSH terms

• Criminogenic Thinking
• Empathy
• Guilt
• HIV Risk
• Shame
• Substance Abuse
• Substance-Related Disorders

Intervention

Behavioral:
• Impact of Crime Modules
5 session/1 week modules of a restorative justice inspired victim impact group intervention
• TAU
have access to other jail programs and services

Locations

Country	Name	City	State
United States	Fairfax County Adult Detention Center	Fairfax	Virginia

Sponsors (2)

Lead Sponsor	Collaborator
George Mason University	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Recidivism - Self report of arrests and undetected crimes		3 months post-release up to 9 mos
Primary	Acceptability - number of participants who indicate the module was helpful and number who would recommend treatment to a friend		1 week post-treatment up to 2 weeks
Primary	Number of inmates who complete the intervention		5 sessions over a period of 1 week
Secondary	Self reported Substance use and dependence -Texas Christian University measure		3 months post-release up to 9 mos
Secondary	Self reported HIV risk behavior (sex and Intravenous Drug Use) Texas Christian University measure		3 months post-release up to 9 mos
Secondary	Changes in self-reported Shame-proneness from baseline		Changes from pre- to post-treatment up to 12 weeks
Secondary	Changes in self-reported Shame-proneness from baseline		Changes from pre-treatment to 3 mos post-release up to 9 mos
Secondary	Changes in self-reported Guilt-proneness from baseline		Changes from pretreatment to 3 months post-release up to 9 mos
Secondary	Changes in self-reported Guilt-proneness from baseline		Changes from pretreatment to post-treatment up to 12 weeks
Secondary	Changes in self-reported empathy from baseline		changes from pre- to post-treatment up to 12 weeks
Secondary	Changes in self-reported empathy from baseline		changes from pre-treatment to 3 mos post-release up to 9 mos
Secondary	Changes in self reported criminogenic thinking from baseline		changes from pre-treatment to post-treatment up to 12 weeks
Secondary	Changes in self reported criminogenic thinking from baseline		changes from pre-treatment to 3 mos post-release up to 9 mos